# Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

> **NCT00307489** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 106 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** tenofovir DF
- **DRUG:** emtricitabine /tenofovir DF

## Key facts

- **NCT ID:** NCT00307489
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-01
- **Final completion:** 2010-10
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2011-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307489, "Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00307489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*